Gujarat Alkalies and Chemicals Limited (NSE: GUJALKALI) trades at approximately ₹686.90 per share. Because active equity markets experience continuous intraday price movements, real-time quotes, daily trading volumes, and capitalization fluctuations should be verified directly through your financial market terminal or trading platform.
Fate Therapeutics, a prominent clinical-stage biopharmaceutical company focused on programmed cellular immunotherapies, maintains a specialized scientific and corporate workforce of approximately 150 to 200 employees, distributed across its research laboratories and headquarters in California.